Theranos, the 12-year-old Palo Alto-based company working on a smaller, cheaper, alternative to common lab blood tests, has received its first voluntary FDA 510(k) clearance, for its herpes simplex 1 ...
Effects of a deep learning network on imaging quality of low-b-value diffusion–weighted imaging and lesion detection in prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results